News

March 19, 2020March 19, 2020

Dual Immunoglobulin, Aimovig Therapies Safe for MG, Migraines, Report Says

News

Aimovig (erenumab) and the investigational immune therapy subcutaneous immunoglobulin (SCIg) can safely be used simultaneously to treat migraines and myasthenia gravis, according to a recent case report. Both treatments were ... Read more

March 17, 2020March 17, 2020

Increasing Expenses for MG Patients In China Suggest Inadequacy of Current Medical Insurance Policies, Study Says

News

Out-of-pocket expenses for people in China who have myasthenia gravis increased from 2013 to 2015, suggesting that current policies for medical insurance in China are inadequate for those living with ... Read more

March 12, 2020March 12, 2020

Levels of Certain B- and T-cells Linked to Ocular MG Turning Generalized

News

Low blood levels of regulatory immune cells that prevent autoimmune responses, and high levels of antibody-producing memory B-cells may cause ocular myasthenia gravis (MG) to progress to generalized MG, an early study ... Read more

March 10, 2020March 10, 2020

Osteopontin Protein May Worsen MG by Affecting Immune Cells, Study Finds

News

The protein osteopontin, thought to be involved in autoimmunity and inflammation, appears to aggravate myasthenia gravis (MG) progression by promoting the production of self-reacting immune cells while lessening the ... Read more

March 5, 2020March 5, 2020

Complete MG Remission Seen as More Likely in Robot-assisted Thymectomy

News

Surgery to remove the thymus gland, a procedure often recommended to people with myasthenia gravis whether or not tumors exist, is more likely to result in complete disease remission when ... Read more

March 4, 2020March 5, 2020

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

News

In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the ... Read more

March 3, 2020March 3, 2020

HBM9161 Shows Potential to Treat Autoimmune Diseases, Early Data Suggest

News

Harbour BioMed‘s HBM9161 was found to be safe and effective at reducing the levels of autoimmune disease-associated antibodies in many disorders, including myasthenia gravis, a Phase 1 trial shows. ... Read more

March 2, 2020March 2, 2020

Elsevier Opens Books, Review Articles to Rare Disease Researchers Starting Feb. 29

News

Beginning on Feb. 29, Rare Disease Day, chapters from notable scientific books and clinical review articles covering rare disorders will be available free-of-charge from Elsevier. The offer runs through April 30, ... Read more

February 27, 2020February 27, 2020

Advice on Starting Nonprofit Groups for Rare and Other Diseases Focus of NORD Webinar

News

Starting a 501(c)(3) tax-exempt nonprofit isn’t easy, but the National Organization for Rare Disorders gave a few tips for those looking to begin the complex process in its Feb. ... Read more

February 26, 2020February 27, 2020

Mental Health Should Be Clinical Focus of MG Care, Case Report Argues

News

Mental health must be a clinical priority when treating people with myasthenia gravis (MG), in addition to caring for physical symptoms, argues a recent case report. The researchers said ... Read more

Pin It on Pinterest